Effect of 26 weeks of liraglutide treatment on coronary artery inflammation in type 2 diabetes quantified by [ 64 Cu]Cu-DOTATATE PET/CT: results from the LIRAFLAME trial
bit.ly/47IaqNS?utm_medium=social&utm_source=facebook_WWLTV #CancerResearch #GLP1 #Obesity #Cancer #Health #HealthNews #MedicalResearch | WWLTV
Gala GLP-1's stated pricing is positioned within the range of publicly available pricing across telehealth GLP-1 platforms at the time of writing - though direct comparisons require verifying exactly what's included at each tier across platforms, as these structures shift frequently
Monthly costs for therapy range between $300 and $600
Retatrutide, a triple agonist targeting gastric inhibitory polypeptide (GIP), GLP-1, and glucagon receptors, has achieved highly promising outcomes in its phase 2 trial [22], with weight loss up to 24%
It stimulates insulin release, slows gastric emptying, and signals feelings of fullness, which together help regulate blood-sugar levels and control appetite after meals